Latest Impairment News

360 Capital Mortgage REIT (ASX – TCF) has announced a non-renounceable 1-for-1 entitlement offer to raise approximately $45.2 million, aiming to expand its senior loan investments secured by Australian real estate. The offer includes an oversubscription facility and a shortfall offer targeting wholesale and institutional investors.

Ramsay Health Care has clarified that its underlying earnings for FY25 aligned closely with market consensus, despite a significant non-cash impairment impacting statutory profits. The company confirms compliance with ASX disclosure rules amid share price volatility.

Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.

Woolworths Group has confirmed its full-year earnings for 2025 met market expectations, responding comprehensively to ASX inquiries about potential material variances. The retailer’s underlying results closely matched analyst consensus, despite statutory impairments and restructuring costs.

360 Capital Mortgage REIT has introduced a voluntary Distribution Reinvestment Plan allowing unitholders to reinvest monthly distributions into additional units at net asset value without transaction costs. This move aims to enhance investor returns while maintaining capital preservation and transparency.

Rewardle Holdings has cleared a major compliance hurdle by releasing its preliminary report, spotlighting its strategic investment in cardiac MedTech firm CloudHolter and ongoing B2B2C platform development.

Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.

Frontier Digital Ventures reported a 5% decline in revenue but a striking 71% jump in EBITDA for the first half of 2025, driven by margin expansion and operational efficiencies across its classifieds marketplaces in emerging regions.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

PYC Therapeutics has completed dosing in its Phase 1 study of PYC-001 for Autosomal Dominant Optic Atrophy, showing strong safety and early signs of improved vision. The company plans to launch a global Phase 1/2 trial later this year.

oOh!media has confirmed its half-year earnings for 2025 met market expectations, despite a significant non-cash impairment linked to the loss of a key Auckland Transport contract. The company maintains steady operational performance and updated guidance amid evolving market conditions.

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.